NCT07030829

Brief Summary

Common bile duct (CBD) stones are a frequent condition that can lead to severe complications if not treated. The standard approach involves endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and stone extraction using balloons or baskets. However, approximately 10-15% of cases involve "difficult CBD stones" that cannot be removed using conventional methods. According to the European Society of Gastrointestinal Endoscopy (ESGE), difficult CBD stones are characterized by large size (≥15 mm), impaction, multiple stones, difficult locations (e.g., intrahepatic or cystic ducts), or altered anatomy due to previous surgeries. These cases require advanced techniques such as single-operator cholangioscopy (SOC) using the SpyGlass DS system, which allows direct stone visualization and lithotripsy-assisted fragmentation. Two primary lithotripsy methods are available: Electrohydraulic Lithotripsy (EHL): Uses shock waves from electrical energy to break stones. Laser Lithotripsy (LL): Uses laser energy to fragment stones through a water-mediated medium. While both techniques are effective, studies suggest LL has a higher first-attempt stone clearance rate (82-100%) compared to EHL (70.9-75%). However, EHL is more cost-effective and widely available, whereas LL offers greater precision but at a higher cost. Currently, no randomized controlled trial (RCT) directly compares their efficacy, procedural time, complication rates, or operator satisfaction. This study aims to fill that gap by conducting a randomized trial comparing EHL and LL in the treatment of difficult CBD stones. The primary outcome is the success rate of complete stone clearance in the first session, while secondary outcomes include procedural duration, post-procedural complications, and operator satisfaction. The findings will provide critical evidence for optimizing endoscopic stone management, improving patient outcomes, and guiding healthcare resource allocation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Mar 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

February 26, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 22, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 22, 2025

Status Verified

May 1, 2025

Enrollment Period

1.8 years

First QC Date

February 26, 2025

Last Update Submit

June 12, 2025

Conditions

Keywords

Common bile duct stonesCBD stonesDifficult CBD stonesERCPSpyglassCholangioscopyLithrotripsyLaser lithrotripsyEHLElectrohydraulic Lithotripsy

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of Electrohydraulic Lithotripsy (EHL) and Laser Lithotripsy (LL)

    Comparison of the effectiveness of Electrohydraulic Lithotripsy (EHL) and Laser Lithotripsy (LL) by examining the success rate of complete stone removal on the first procedure.

    During the procedure

Secondary Outcomes (5)

  • Procedure time

    Periprocedural (Total procedure time usually 1-2 hours)

  • Number of catheters used

    Periprocedural

  • Physician satisfaction

    Periprocedural

  • Procedure-related adverse events

    up to 2 weeks after the procedure

  • Length of hospital stay

    through after procedure average 1-2 weeks

Study Arms (2)

Laser Lithotripsy

EXPERIMENTAL
Device: Laser Lithotripsy

Electrohydraulic Lithotripsy

EXPERIMENTAL
Device: Electrohydraulic Lithotripsy

Interventions

Laser Lithotripsy

Laser Lithotripsy

Electrohydraulic Lithotripsy

Electrohydraulic Lithotripsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged \>18 years
  • Difficult CBD stone
  • Large CBD stone (stone \> 1.5 cm) or Stone impaction or CBD stones that were not completely removed using conventional techniques.

You may not qualify if:

  • Pregnancy
  • Unstable vital signs
  • Severe comorbidities
  • Uncorrected coagulopathy
  • Surgically altered anatomy
  • Unable to complete informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Bangkok, 10120, Thailand

RECRUITING

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Bangkok, 10ึ700, Thailand

RECRUITING

MeSH Terms

Conditions

Gallstones

Interventions

Lithotripsy, LaserLithotripsy

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsAblation TechniquesSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Officials

  • Varayu Prachayakul, MD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ronnakorn Kongsakon, MD

CONTACT

Chutikarn Wittayalikit, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 26, 2025

First Posted

June 22, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

We are willing to provide our data to researchers who require it. For example, those who want to do systematic review and meta-analysis.

Shared Documents
STUDY PROTOCOL
Time Frame
Other researchers can contact us anytime.
Access Criteria
We will provide our protocol and/or data upon request.

Locations